Excited to share our investigation of a very unique Ebola patient in DRC/2019 just came out. The patient relapsed from this initial infection and unfortunately sparked a large transmission chain. Fantastic work with @inrb_kinshasa and Mike Wiley‘s lab https://t.co/dHGBPGUiWL
@ChrisJBakke If this is turning out to be a profitable business 😅 So far, this is an exercise in setting VC money on fire while displaying actually profitable businesses…some say.
Please see below, VIR is looking for two SRAs in Virology – one position will be directly working with me on HIV broadly neutralizing antibody projects 🙂 If you’re interested please apply and reach out on LinkedIn/DM.
https://t.co/tZAGQKG0eU
https://t.co/2WXdlaOG9W
We are looking for two SRAs in Virology with focus on HIV or HBV. If you have experience in cell culture/mol. bio, and are passionate to develop therapies against infectious diseases, check out these job opportunities. Located in our beautiful SF/Mission Bay HQ. Links below 👇
Today we're officially announcing and opening applications to Campus 🏛️
1/ A “school” for the soul, intellect, and inner-child:
🔭community-created curriculum exploring our curiosities
🌱 50+ circles, salons, juntos and extracurriculars
🤓 "nerd prom" at end of the qtr
Today @ScienceTM how a 1st-in-class #antibody cocktail targets #LassaFever virus. #CryoEM & wetlab explain how the mAbs navigate a thick #glycan shield & use 3 complementary mech. of neut. The finisher: novel vaccine candidate to elicit more Ab like these.
https://t.co/AJI10cOek7
@kanjun@michael_nielsen I will work my way through your funding manifesto, so excited :)
In the meantime, if you want to read one of the most poignant and funny criticisms of our current funding system, you have to read this legendary article called "Goodbye, Columbus": https://t.co/fgTAeCWorh
New #Ebola case in Beni, DR Congo is not a new spillover. Great work by @PlacideMbala, @labgenpath, @Inrb_goma, and others showed the new case is linked to the 2018-2020 Nord Kivu outbreak.
https://t.co/MoOnLDxdp9
#Ebola may be back in DRC's North Kivu. Testing is underway on samples from a 46 yo woman who died at Beni on Aug. 15 of Ebola-like symptoms. https://t.co/8MeC8wOY9g
I’m a partner at A16Z and we just had a very compelling healthcare pitch from a second-time founder.
Blood tests, but it only requires one drop of blood.
How cool!
I invested $351 million on the spot, making this our largest deal ever.
Will share more in a blog post soon!
Okay, this is the biggest bullshit I've read all day; maybe there is no hope for some SV VCs – no accountability, no ethics.
Maybe Elizabeth Holmes will need a cool $100m in prison for the next big thing in diagnostics; I'm sure @a16z is on standby.
https://t.co/C7ZvmERXi9